A culture medium for alveolar epithelial cells, a culture method therefor and its application
By using a combination of Advanced DMEM, epithelial cell culture medium, and trans-4-hydroxy-L-proline, the culture conditions were optimized, solving the problems of low proliferation efficiency and stable passage of alveolar epithelial cells. This enabled the rapid expansion and purification of ATⅠ cells, making them suitable for lung disease research.
Patent Information
- Application Number
- CN202311207737.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-18
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-09-18
AI Technical Summary
Existing alveolar epithelial cells have low proliferation efficiency, and type I alveolar epithelial cells are difficult to passage stably. In traditional culture systems, cells have long latency periods and low fusion rates.
Advanced DMEM and epithelial cell culture medium were used as a composite basal medium, with trans-4-hydroxy-L-proline added as an additive. Combined with AB plasma and MEM vitamin solution, culture conditions such as temperature, CO2 concentration and humidity were optimized to achieve stable expansion of ATⅠ cells.
It shortens the latency period of ATⅠ cells, improves cell proliferation efficiency and fusion rate, enables stable passage and large-scale expansion of ATⅠ cells, avoids animal-derived viral contamination, and is suitable for rapid and large-scale cell production.
Smart Images

Figure CN117070441B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of alveolar epithelial cell culture technology, and in particular to an alveolar epithelial cell culture medium, culture method and its application. Background Technology
[0002] Alveolar epithelium is composed of two cell types: type I alveolar epithelial cells (AT I) and type II alveolar epithelial cells (AT II). Traditionally, AT II cells were considered the biologically active cells in the alveolar epithelium, while terminally differentiated AT I cells passively participated in the formation of the air-blood barrier, without proliferation or plasticity. However, recent studies have found that AT I cells are not only terminally differentiated in the traditional sense but also possess diverse biological functions and play a role in injury repair. Although AT I cells account for only 8% of the total lung cells, they cover 95%–98% of the alveolar surface area. AT I cells participate in the formation of the air-blood barrier and are crucial for normal gas exchange. Due to the fragility of AT I cells, the lack of biological markers, and the relative difficulty in isolation, current research on AT I mainly uses AT I-like cells differentiated from AT II cells, but their biological characteristics differ somewhat from those of AT I cells.
[0003] Existing technologies typically utilize enzymatic digestion, IgG adhesion, and immunomagnetic bead technology to isolate high-purity primary ATⅠ cells and conduct preliminary observations of their biological characteristics. However, current technologies are limited to successfully obtaining primary ATⅠ cells, but cannot achieve stable passage. The existing routine culture system for ATⅠ cells is high-glucose DMEM medium + 10% FBS + 100 μg / mL penicillin and streptomycin. The cell latency period is 3 days, and the cells begin to proliferate from 3 to 5 days. At 8 days, the confluence rate is only 60%. Summary of the Invention
[0004] The purpose of this invention is to provide a culture medium for alveolar epithelial cells that can solve the problem of low proliferation efficiency of existing alveolar epithelial cells, and to provide a method for expanding alveolar epithelial cells that can solve the problem of unstable passage of existing type I alveolar epithelial cells.
[0005] To achieve the above-mentioned objectives, the present invention provides the following technical solution: This invention provides a culture medium for alveolar epithelial cells, comprising basal culture medium, AB plasma, trans-4-hydroxy-L-proline, and MEM vitamin solution; The basal culture medium includes Advanced DMEM and epithelial cell culture medium, and the volume ratio of Advanced DMEM to epithelial cell culture medium in the basal culture medium is 1:0.8~1.2.
[0006] Preferably, the amount of AB plasma added is 3-8% of the volume of the basal culture medium; The amount of trans-4-hydroxy-L-proline added is 20~80 mmol / L.
[0007] The present invention also provides the application of the above-mentioned alveolar epithelial cell culture medium in the expansion culture and / or passage culture of alveolar epithelial cells.
[0008] Preferably, the alveolar epithelial cells are type I alveolar epithelial cells.
[0009] The present invention also provides a method for culturing alveolar epithelial cells, wherein alveolar epithelial cells are inoculated into the above-mentioned alveolar epithelial cell culture medium and cultured.
[0010] Preferably, the inoculum size of the alveolar epithelial cells is 1×10⁻⁶. 4 ~5×10 5 cell / mL.
[0011] Preferably, the culture is carried out at a temperature of 35~38℃.
[0012] Preferably, the CO2 concentration used in the culture is 3-8%.
[0013] Preferably, the humidity used in the cultivation is 93-98%.
[0014] Preferably, the culture medium is changed every 1 to 3 days during the culture process.
[0015] The technical effects and advantages of this invention are as follows: This invention utilizes Advanced DMEM and epithelial cell culture medium as a composite basal medium, and uses trans-4-hydroxy-L-proline as a medium additive. Through synergistic effects with other reagents, it effectively maintains the viability of ATⅠ cells, enabling the rapid acquisition of a sufficient number of ATⅠ cells. The alveolar epithelial cell culture medium provided by this invention can shorten the latency period of purified primary cells while maintaining cell properties, preventing differentiation and aging, thereby activating cell proliferation and initiation into the cell cycle. The alveolar epithelial cell culture medium provided by this invention can simultaneously meet the needs of primary and passaged ATⅠ cells, allowing for stable expansion of ATⅠ cells in vitro for 3-5 generations, thus achieving large-scale in vitro expansion and mass production of ATⅠ cells.
[0016] The alveolar epithelial cell culture method provided by this invention not only avoids the introduction of animal-derived viral contamination by components such as fetal bovine serum, but also has the advantages of simple operation. It can be used for rapid and large-scale cell production, providing a reliable basis for research on the mechanism of the air-blood barrier and lung diseases characterized by ATⅠ injury. Attached Figure Description
[0017] Figure 1 This is a cell proliferation curve. Figure 2 This is a schematic diagram showing the expression results of T1α in ATⅠ cells; Figure 3 This is a schematic diagram showing the expression results of T1α in MLE-12 cells; Figure 4 Image of P1 cells from MLE-12 (mouse lung epithelial cells); Figure 5 This is an image of P1 cells, which are type I lung epithelial cells (ATⅠ cells); Figure 6 Image of P3 cells obtained from MLE-12 (mouse lung epithelial cells) cultured according to this invention; Figure 7 This is a cell image of P3 obtained from type I lung epithelial cells (ATⅠ cells) cultured according to this invention. Detailed Implementation
[0018] This invention provides a culture medium for alveolar epithelial cells, comprising a basal culture medium, AB plasma, trans-4-hydroxy-L-proline, and MEM vitamin solution; the basal culture medium includes Advanced DMEM and epithelial cell culture medium, wherein the volume ratio of Advanced DMEM to epithelial cell culture medium in the basal culture medium is 1:0.8~1.2, preferably 1:0.9~1.1; in this invention, the amount of AB plasma added is preferably 3~8% of the volume of the basal culture medium; the amount of trans-4-hydroxy-L-proline added is preferably 20~80 mmol / L; the concentration multiple of the stock solution is preferably 100×, and the addition multiple is preferably 1~3×.
[0019] The present invention also provides the application of the above-mentioned alveolar epithelial cell culture medium in the expansion culture and / or passage culture of alveolar epithelial cells. The alveolar epithelial cells mentioned in the present invention can be alveolar epithelial cells containing both type I and type II alveolar epithelial cells, purified type I alveolar epithelial cells, or purified type II alveolar epithelial cells, preferably purified type I alveolar epithelial cells.
[0020] The present invention also provides a method for culturing alveolar epithelial cells, wherein alveolar epithelial cells are seeded into the above-mentioned alveolar epithelial cell culture medium and cultured. Preferably, the seeding amount of alveolar epithelial cells is 1×10⁻⁶. 4 ~5×10 5 cell / mL, more preferably 5×10 4 ~2×10 5 The cell / mL, the culture temperature is preferably 35~38℃, more preferably 36.5~37.5℃, the CO2 concentration is preferably 3~8%, more preferably 4~6%, the humidity is preferably 93~98%, more preferably 94~96%, and the culture medium is preferably changed every 1~3 days during the culture process. Changing the culture medium every 1~3 days means aspirating the culture medium and replacing it with fresh culture medium.
[0021] The technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0022] The reagents and biological materials used in these examples are sourced from: Epithelial cell culture medium: Product name Epithelial Cell Medium, purchased from ScienCell, catalog number: 4101. Each aliquot contains 500 ml of basal culture medium, 10 ml of fetal bovine serum (FBS, Cat. No. 0010), 5 ml of epithelial growth factor (EpiCGS, Cat. No. 4152), and 5 ml of penicillin / streptoxin solution (P / S, Cat. No. 0503). Advanced DMEM, purchased from Gibco (product number 12491023), is an upgraded version of the DMEM basal medium formulation. It is rich in normal serum components, but requires 50-90% less FBS. trans-4-hydroxy-L-proline (Batch No.: H0296, Supplier: Nantong Jiaxingtai Biotechnology Co., Ltd.) MEM Vitamin Solution (100×, Product No.: 11120052; Brand: Gibco™); Human-derived AB plasma is derived from AB type umbilical cord blood plasma: the colloidal gold test of the umbilical cord blood plasma, the test results for syphilis, HIV, hepatitis B, and hepatitis C were negative, and the AB type umbilical cord blood was centrifuged at 1800 rpm for 15 min; the supernatant plasma was collected, and the plasma was transferred to 56℃ for inactivation for 30 min; the inactivated plasma was transferred to -20℃ for freezing for 15 min; the frozen inactivated plasma was transferred to a centrifuge and centrifuged at 3000 rpm for 20 min, and the supernatant was transferred to a new centrifuge tube for later use.
[0023] Isolation and purification of ATⅠ mouse epithelial cells: A. Preparation of lung single-cell suspension: Rats were weighed, anesthetized, and heparinized throughout the body. The lungs were perfused with sterile PBS (containing 50 U / mL heparin) until they turned completely white. The alveolar cavities were irrigated three times with PBS (pH 7.4, 5 mmol / L EGTA, 5 mmol / L EDTA) preheated at 37°C. 10 ml of preheated Dispase (10 U / ml) was instilled into the lungs and digested at 37°C for 40 min, with mechanical shaking during digestion. After digestion, the lung lobes were retained, and 1 mL of dispersion (RPMI 1640 medium, 20% FBS, 100 μg / ml DNase I) was added. The cells were then thoroughly minced. The mixture was filtered once through a 100 μm filter and twice through a 40 μm filter. The filtrate was collected, centrifuged, the supernatant was discarded, and the cell pellet was resuspended to obtain a single-cell suspension.
[0024] Purification of B. ATⅠ: Single-cell suspension was transferred to a culture dish coated with rat IgG and incubated at 37°C for 60 min. Non-adherent cells were collected, centrifuged, and resuspended in 0.5 ml of antibody incubation medium (RPMI 1640 medium, 1% FBS, 50 μg / ml DNase Ⅰ); 5 μg of rabbit anti-rat T1α was added, and the cells were incubated on a shaker at 4°C for 35 min. The cells were washed twice with PBS (pH 7.2, 0.5% BSA, 2 mmol / L EDTA), centrifuged, and resuspended in 80 μL of antibody incubation medium. 20 μL of magnetically bead-labeled goat anti-rabbit IgG was added, and the cells were incubated at 4°C for 15 min. The cells were washed once with PBS (pH 7.2, 0.5% BSA, 2 mmol / L EDTA) and then separated twice using a column. The cells were washed four times with PBS (pH 7.2, 0.5% BSA, 2 mmol / L EDTA), 0.5 mL each time. The column was removed, and positive cells were collected.
[0025] MLE-12 mouse lung epithelial cells: purchased from a cell resource platform, catalog number: IM-M015.
[0026] Example 1 Prepare the basal culture medium: 50% Advanced DMEM + 50% epithelial cell culture medium, with the following components added: Human-derived AB plasma was added at 5% of the basal culture medium volume. trans-4-hydroxy-L-proline, added at 20 mmol / L; MEM vitamin solution (original concentration 100×, with 1× added); Resuspend ATⅠ mouse epithelial cells in culture medium, adjust cell density, and add 1×10⁶ cells. 5Cells were seeded at a rate of 12 mL / flask into T75 culture flasks. The cells were then transferred to an environment of 37°C, 5% CO2, and 95% humidity for culture. The medium was changed once after 48 hours. Cell passage was performed when the cell confluence rate reached approximately 90%.
[0027] Example 2 Prepare the culture medium: 50% Advanced DMEM + 50% epithelial cell culture medium, with the following components added: Human-derived AB plasma was added at 5% of the basal culture medium volume. trans-4-hydroxy-L-proline, added at 40 mmol / L; MEM vitamin solution (original concentration 100×, with 2× added); MLE-12 mouse lung epithelial cells were resuspended in culture medium, and the cell density was adjusted to 1×10⁶ cells / mL. 5 Cells were seeded at a rate of 12 mL / flask into T75 culture flasks. The cells were then transferred to an environment of 37°C, 5% CO2, and 95% humidity for culture. The medium was changed once after 48 hours. Cell passage was performed when the cell confluence rate reached approximately 90%.
[0028] Example 3 Prepare the culture medium: 50% Advanced DMEM + 50% epithelial cell culture medium, with the following components added: Human-derived AB plasma was added at 5% of the basal culture medium volume. trans-4-hydroxy-L-proline, added at 60 mmol / L; MEM vitamin solution (original concentration 100×, with 1× added); Resuspend ATⅠ mouse epithelial cells in culture medium, adjust cell density, and add 1×10⁶ cells. 5 Cells were seeded at a rate of 12 mL / flask into T75 culture flasks. The cells were then transferred to an environment of 37°C, 5% CO2, and 95% humidity for culture. The medium was changed once after 48 hours. Cell passage was performed when the cell confluence rate reached approximately 90%.
[0029] Example 4 Prepare the culture medium: 50% Advanced DMEM + 50% epithelial cell culture medium, with the following components added: Human-derived AB plasma was added at 5% of the basal culture medium volume. trans-4-hydroxy-L-proline, added at 80 mmol / L; MEM vitamin solution (original concentration 100×, with 2× added); Resuspend ATⅠ mouse epithelial cells in culture medium, adjust cell density, and add 1×10⁶ cells. 5 Cells were seeded at a rate of 12 mL / flask into T75 culture flasks. The cells were then transferred to an environment of 37°C, 5% CO2, and 95% humidity for culture. The medium was changed once after 48 hours. Cell passage was performed when the cell confluence rate reached approximately 90%.
[0030] Comparative Example 1 Preparation of culture medium: The basic culture medium is high-glucose DMEM medium, with the addition of FBS at a final concentration of 10%, penicillin and streptomycin at a final concentration of 100 μg / mL; Resuspend ATⅠ mouse epithelial cells in culture medium, adjust cell density, and add 1×10⁶ cells. 5 Cells were seeded at a rate of 12 mL / flask into T75 culture flasks. The cells were then transferred to an environment of 37°C, 5% CO2, and 95% humidity for culture. The medium was changed once after 48 hours. Cell passage was performed when the cell confluence rate reached approximately 90%.
[0031] Comparative Example 2 Preparation of culture medium: The basic culture medium is high-glucose DMEM medium, with the addition of FBS at a final concentration of 10%, penicillin and streptomycin at a final concentration of 100 μg / mL; MLE-12 mouse lung epithelial cells were resuspended in culture medium, and the cell density was adjusted to 1×10⁶ cells / mL. 5 Cells were seeded at a rate of 12 mL / flask into T75 culture flasks. The cells were then transferred to an environment of 37°C, 5% CO2, and 95% humidity for culture. The medium was changed once after 48 hours. Cell passage was performed when the cell confluence rate reached approximately 90%.
[0032] Comparative Example 3 The only difference from Example 1 is that 100% Advanced DMEM is used as the basal culture medium.
[0033] Comparative Example 4 The only difference from Example 1 is that 100% epithelial cell culture medium is used as the basal culture medium.
[0034] Comparative Example 5 The only difference from Example 1 is that the basal culture medium is replaced with 20% Advanced DMEM + 80% epithelial cell culture medium.
[0035] Experimental Example 1 Cells were cultured according to the methods of Example 1 (denoted as ATⅠ cells), Example 2 (denoted as MLE-12), and Comparative Example 1. Primary isolated cells were seeded into 12-well plates, 2 × 10⁶ cells per well. 4Cells were seeded in two plates. Counting began immediately after seeding and continued every 24 hours, counting three wells each time. The mean and standard deviation were calculated. Specific counting method: The culture medium in the wells was aspirated, the cells were washed twice with PBS, and 0.5 mL of pre-warmed 0.25% trypsin was added. The cells were digested at 37°C for 5-7 minutes, with the bottom of the wells gently tapped several times during digestion. Once all cells were observed to be suspended under a microscope, the cells were transferred to 1.5 mL EP tubes, centrifuged at 1000 rpm for 5 minutes, the supernatant was discarded, and the cells were resuspended in 100 μL of PBS. The mixture was thoroughly mixed, and 20 μL of the cell suspension (cell suspension: trypan blue = 1:1, volume ratio) was added to a CountStar counting chamber for analysis. The results were recorded as shown in Table 1 below, and a growth curve was plotted. Figure 1 As shown.
[0036] Table 1 Cell Count Results
[0037] The proliferation curves of Comparative Example 1 and Example 1 show that the culture medium provided by this invention has a significant promoting effect on the proliferation of ATⅠ cells. Cells in Comparative Example 1 entered the proliferation phase on day 5 and the exponential proliferation phase on day 6, while ATⅠ cells cultured using the culture medium of this invention entered the proliferation phase on day 2 and completed cell proliferation by day 6, reaching a plateau phase. This indicates that the culture system of this invention can significantly shorten the latency period of ATⅠ cells, greatly promote ATⅠ cell proliferation, and shorten the entire culture cycle. The proliferation curves of Example 1 and Example 2 show that the proliferation curves of the two cell types are basically consistent, with a cell latency of 2 days in both cases, and both entering the plateau phase on day 6. This indicates that this invention can effectively shorten the culture cycle of lung epithelial cells and is suitable for ATⅠ cell culture.
[0038] Experimental Example 2 T1α is a transmembrane protein that has been shown to be specifically expressed in ATⅠ cells in the lungs and has been widely used for the isolation and identification of ATⅠ cells.
[0039] Daughter cells were obtained using the culture methods described in Examples 1-2 and Comparative Examples 3-5 (the original culture system was maintained during passage culture), and were then separated and spread onto slides. T1α expression was detected using immunofluorescence staining. Cell counts were performed, and the cell concentration was adjusted to 1×10⁻⁶ cells / cells. 6 Cells were collected at a density of 10 cells / ml and crawled onto slides. The following day, the slides were fixed in acetone solution and placed on ice for 15 min. They were then blocked with 10% goat serum at 37°C for 1 h, and donkey anti-goat IgG / AF549 (1:400) was added and incubated at 37°C in the dark for 1 h. The nuclei were stained with DAPI, the slides were mounted, and fluorescence was observed and collected. Cells were counted in random fields under a microscope, and the percentage of positive cells was calculated.
[0040] The results are as follows Figures 2-3Immunohistochemistry showed that the cells were mainly oval or round in shape, with the nuclei stained blue and the cytoplasm of all cells stained red. The red color indicates that the cells obtained were type I lung epithelial cells. Figure 2 The ATⅠ progeny cells isolated in Example 1 of this invention were subjected to cell smear analysis, and the expression of T1α was detected by immunofluorescence staining. The results showed that the positive rate was 91.0% ± 0.6%. Figure 3 The MLE-12 progeny cells obtained in Example 2 were subjected to cell smearing and immunofluorescence staining to detect the expression of T1α. The results showed that the positive rate was 43.7% ± 1.2%.
[0041] The percentage of T1α expression in daughter cells of different generations is shown in Table 2.
[0042] Table 2. Detection results at different passage numbers
[0043] As shown in Table 2, the expression of T1α protein in ATⅠ cells is stable under the culture system of this invention. With increasing passage number, the purity of ATⅠ cells increased from 90% in passage P2 to 95% in passage P5; cell purity was further improved.
[0044] MLE-12 contains both type I and type II lung epithelial cells. The content of type I lung epithelial cells (ATⅠ cells) gradually increases with the cell passage, rising from 44% in P2 to about 64% in P5. This indicates that the culture system of the present invention is suitable for the culture of both type I and type II lung epithelial cells, and is especially suitable for the in vitro purification of type I lung epithelial cells (ATⅠ cells).
[0045] ATⅠ cells were cultured in the same medium as Comparative Example 1, and the cell purity decreased from 92.9% in the P2 generation to 86.3% in the P5 generation; the cell purity continued to gradually decrease.
[0046] ATⅠ cells were cultured in the same medium as Comparative Example 2, and the cell purity decreased from 93.5% in the P2 generation to 85.0% in the P5 generation; the cell purity continued to decrease gradually.
[0047] ATⅠ cells were cultured in the same medium as Comparative Example 3, and the cell purity decreased from 91.9% in the P2 generation to 88.6% in the P5 generation; the cell purity continued to gradually decrease.
[0048] ATⅠ cells were cultured in the same medium as Comparative Example 4, and the cell purity decreased from 91.4% in the P2 generation to 88.2% in the P5 generation; the cell purity continued to decrease gradually.
[0049] ATⅠ cells were cultured in Comparative Example 5, and the cell purity decreased from 92.1% in P2 generation to 87.5% in P5 generation; the cell purity continued to gradually decrease.
[0050] In summary, ATⅠ cells can proliferate stably in the system of this invention and can be purified in one step.
[0051] Experimental Example 3 The ATⅠ progeny cells cultured in Example 1 and the MLE-12 progeny cells cultured in Example 2 were observed (4×), as shown below. Figures 4-7 As shown.
[0052] The results show: Figure 4 The P1 cells of MLE-12 (mouse lung epithelial cells) contain cells with different morphologies, which may be related to the presence of type I and type II lung epithelial cells. The cells as a whole appear as paving stones. Figure 5 Type I lung epithelial cells (ATⅠ cells) P1 cells have a uniform, round, spindle-shaped morphology. Cell fusion results in a "paving stone" pattern, which is relatively... Figure 4 In other words, Figure 5 The cell morphology is more uniform and consistent; Figure 6 The P3 cells obtained from MLE-12 (mouse lung epithelial cells) cultured using this invention exhibit consistent cell morphology, clear edges, prominent cytoplasm, and a rounded polygonal shape; the overall cell structure resembles cobblestones, representing a typical epithelial cell morphology. The P3 cells obtained from type I lung epithelial cells (ATⅠ cells) cultured using this invention are similar to… Figure 6 The cells have a consistent morphology. ATⅠ cells have clear edges, prominent cytoplasm, and a rounded polygonal shape; the cells as a whole resemble paving stones; this is the typical morphology of epithelial cells.
[0053] Both cell types adhered to the culture wall on day 2, exhibiting polygonal and rounded cell shapes. The third-generation daughter cells, obtained through subculturing, showed good proliferation on day 3, with fusion sites resembling cobblestones, consistent with the biological characteristics of epithelial cells. This also demonstrates that the culture medium provided by this invention can effectively shorten the culture cycle of alveolar epithelial cells and can be used to produce alveolar epithelial cells of superior quality.
[0054] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. An alveolar epithelial cell culture medium, characterized by, Includes basal culture medium, AB plasma, trans-4-hydroxy-L-proline, and MEM vitamin solution; The basal culture medium includes Advanced DMEM and epithelial cell culture medium, and the volume ratio of Advanced DMEM to epithelial cell culture medium in the basal culture medium is 1:0.8~1.2; The AB plasma is human-derived AB type umbilical cord plasma; The amount of AB plasma added is 3-8% of the volume of the basal culture medium; The amount of trans-4-hydroxy-L-proline added is 20~80 mmol / L.
2. The use of the alveolar epithelial cell culture medium according to claim 1 in the expansion culture and / or passage culture of alveolar epithelial cells.
3. Use according to claim 2, characterized in that, The alveolar epithelial cells are type I alveolar epithelial cells.
4. A method for culturing alveolar epithelial cells, comprising the steps of, The alveolar epithelial cells were seeded into the alveolar epithelial cell culture medium of claim 1 and cultured.
5. The alveolar epithelial cell culture method according to claim 4, wherein, The seeding amount of the alveolar epithelial cells is 1 x 10 4 5 x 10 5 cells / mL.
6. The method of claim 4, wherein the lung alveolar epithelial cells are derived from a human. The culture was conducted at a temperature of 35-38℃.
7. The method of claim 4, wherein the lung alveolar epithelial cells are derived from a human. The CO2 concentration used in the culture is 3-8%.
8. The method of claim 4, wherein the lung alveolar epithelial cells are derived from a human. The humidity used for the culture is 93-98%.
9. The method of claim 4, wherein the lung alveolar epithelial cells are derived from a human. The culture medium is changed every 1 to 3 days during the cultivation process.
Citation Information
Patent Citations
Mixing stem cell injection and preparation method thereof
CN103330720A
Method for inducing human epidermal stem cells into corneal epithelial cells
CN109517051A
